Back to Journals » Drug Design, Development and Therapy » Volume 8

Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells [Retraction]

Authors Cheng M, Xu H, Wang Y, Chen H, He B, Gao X, Li Y, Han J, Zhang Z

Received 20 June 2014

Accepted for publication 20 June 2014

Published 8 July 2014 Volume 2014:8 Pages 921—922

DOI https://doi.org/10.2147/DDDT.S69726

Cheng M, Xu H, Wang Y, et al. Drug Des Devel Ther. 2013;7:1287–1299.
 
It has come to the notice of this journal that the published paper:
Cheng M, Xu H, Wang Y, et al. Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells. Drug Des Devel Ther. 2013;7:1287–1299.
 
Plagiarised the work of:
Cheng M, Gao X, Wang Y, et al. Synthesis of Glycyrrhetinic Acid-Modified Chitosan 5-Fluorouracil Nanoparticles and Its Inhibition of Liver Cancer Characteristics in Vitro and in Vivo. Marine Drugs. 2013;11(9):3517–3536.

The first author, Mingrong Cheng, brought this to our attention, has admitted the fault was his own, due to lack of experience and understanding, and apologized.                   
 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]